Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Catenai investee Alludium progresses strategic partnerships

(Sharecast News) - Catenai made a strategic update on its portfolio company Alludium on Monday, which has secured places in both the AWS Activate and Atlassian for Startups programmes, enhancing its platform capabilities in AI infrastructure and productivity integration. Alludium, backed by a founding team with deep ties to senior leadership across global tech firms, aimed to build a fully-integrated AI agent platform.

Its acceptance into Amazon Web Services' Activate programme would provide access to enterprise-grade infrastructure, scalable AI architecture, and early use of AWS tools as it expands its AI capabilities, Catena explained.

The AIM-traded company said Alludium said it had also joined Atlassian's startup initiative, gaining access to a suite of tools widely used in software development and business collaboration.

Catenai said that would allow Alludium's AI agents to function natively within Atlassian environments, enabling deeper automation and workflow integration beyond standard APIs.

The programme entries followed Alludium's earlier inclusion in the Nvidia Inception programme, further reinforcing its positioning within the advanced AI and developer ecosystem.

"Partnerships and working relationships are critical to what we're building at Alludium," said Alludium chief executive officer John Frizelle.

"Having enjoyed a decade-long relationship with AWS as an engineer, founder and investor, I'm delighted to bring this long-standing working partnership to bear as we build out Alludium."

Frizelle said that, having spoken at AWS annual conferences and mentored as an investor on its Emerging Technology Accelerator programme, it was "great to be back" working on a startup engineering level.

"Atlassian's suite powers collaboration for millions of teams worldwide.

"This $50bn-plus company is the backbone of many AI developer operations."

At 1525 BST, shares in Catenai were down 5.09% at 0.38p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.